Full name
ALPHA PHARMACEUTICAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.90.Z - Non-specialized wholesale trade
47.19.Z - Retail trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
52.10.B - Warehousing and storage of other goods
70.22.Z - Head office activities and management consultancy
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | 0 | 0,1 | 245,3 |
EBITDA | 0,1 | 0 | 0,1 | 388,3 |
Short time liabilities | 0 | 0 | 0,1 | 286,7 |
Equity capital | 0,2 | 0,2 | 0,3 | 34,6 |
Operating profit (EBIT) | 0,1 | 0 | 0,1 | 388,3 |
Assets | 0,2 | 0,2 | 0,4 | 61,8 |
Net profit (loss) | 0,1 | 0 | 0,1 | 259 |
Cash | 0,2 | 0,2 | 0,3 | 24,4 |
Net income from sale | 0,5 | 0,4 | 1,1 | 206,3 |
Liabilities and provisions for liabilities | 0 | 0 | 0,1 | 290,9 |
Working assets | 0,2 | 0,2 | 0,4 | 52,8 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 47,3 | 9,6 | 25,7 | 16,1 |
Equity capital to total assets | 82,4 | 89,4 | 74,4 | -15 |
Gross profit margin | 19,9 | 6,9 | 7,7 | 0,8 |
EBITDA Margin | 20,6 | 5,9 | 9,4 | 3,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 29 | 26 | 33 | 7 |
Current financial liquidity indicator | 5.680848598480225 | 9.425482749938965 | 3.6842658519744873 | -5,7 |
Net dept to EBITDA | -1.7633039951324463 | -9.285164833068848 | -2.3659515380859375 | 6,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane